With so many shares to choose from on the ASX, it can be hard to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.
Three top ASX shares leading brokers have named as buys this week are listed below. Here's why they are bullish on them:
Airtasker Ltd (ASX: ART)
According to a note out of Morgans, its analysts have retained their add rating and $1.05 price target on this small jobs marketplace provider. Whilst the broker acknowledges the current volatile market conditions and broader sector sentiment, it continues to remain attracted to the strong growth opportunity ahead for Airtasker. This is based on the company successfully implementing its strategy of penetrating the "prodigious TAM opportunity" both at home and overseas. The Airtasker share price is trading at 35 cents on Monday.
CSL Limited (ASX: CSL)
A note out of Macquarie reveals that its analysts have retained their outperform rating and $329.50 price target on this biotherapeutics company's shares. Macquarie highlights that CSL's recent phase 3 trial of garadacimab was successful and brings the hereditary angioedema (HAE) treatment closer to approval. The broker believes it could command almost half of the market in the coming years if it is approved by regulators. The CSL share price is fetching $283.09 today.
GPT Group (ASX: GPT)
Analysts at Citi have upgraded this property company's shares to a buy rating with a $4.90 price target. The broker made the move on valuation grounds after significant weakness in 2022. Citi highlights that GPT's shares have fallen ~25% year to date and are now trading at a ~35% discount to NTA with a forward PE of ~12x. In Citi's view, this is starting to present a reasonable margin of safety. The GPT share price is trading at $4.13 on Monday.
